Slide 1: Capital raise
Capital raise 7 May 2026
Slide 2: Disclaimer
Disclaimer THIS DOCUMENT AND ITS CONTENTS ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, OR SOUTH AFRICA, OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
Slide 3: Accelerating Intrum's strategy: Fully guaranteed SEK 7.5 billion capital raise
Accelerating Intrum’s strategy Fully guaranteed SEK 7.5 billion capital raise Shorten deleveraging path Enhance core capabilities Use of net SEK 5 billion proceeds Remainder reducing net debt Approx. supporting growth & profitability 1 Improved Investing Deleverage cashflow Flexibility to pursue att
Slide 4: Strengthening the balance sheet and creating financial flexibility
Strengthening the balance sheet and creating financial flexibility • Strengthening the balance sheet materially and accelerating the deleveraging path by 2 years • Improving refinancing profile and a stronger credit rating trajectory • Reducing funding costs and improving access to capital markets •
Slide 5: Capital raise is expected to fast track the organic plan and materially improve KPIs
Capital raise is expected to fast track the organic plan and materially improve KPIs P&L drivers and expected development over time (pre post capital raise), SEK 2025 2026 2027 2028 2029 2030 Servicing income 13.8 BN Total costs adj. 12.3 BN -5% Interest cash expense 3.5 BN Portfolio investments 1.2
Slide 6: Capital raise is expected to accelerate the deleveraging path by two years
Capital raise is expected to accelerate the deleveraging path by two years Total Leverage Servicing Leverage 6,0x 9,0x 8,1x 5,3x 7,9x 4,8x 1 8,0x 5,0x 4,4x 7,0x 4.6x 2 6,0x 1 4,0x As of 6,0x Mar-26 3.0 -3.5x 5.8x 2 5,0x As of 3,0x Mar-26 ~3.0x 4,0x 3,0x 2,0x 3,0x ~3.0x 2,0x 1,0x 1,0x 0,0x 0,0x 2023A
Slide 7: Capital raise structure and process
Capital raise structure and process Fully guaranteed transaction with strong shareholder support • Directed issue supported by investors including, Kistefos AS, Funds managed by Carnegie Fonder, Funds managed by DNB ~SEK 1.5bn directed issue to selected Asset Management, Toluma AS institutional inve